Intrinsic Value of S&P & Nasdaq Contact Us

XOMA Corporation XOMAO NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
66/100
3/7 Pass
SharesGrow Intrinsic Value
$14.46
-43.5%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

XOMA Corporation (XOMAO) trades at a trailing P/E of 22.0, forward P/E of 23.2. Trailing earnings yield is 4.54%, forward earnings yield 4.31%. PEG 0.80 (Peter Lynch undervalued ≤1.0). Graham Number is $14.50.

Criteria proven by this page:

  • VALUE (88/100, Pass) — P/E is below market average (22.0); PEG ≤ 1.0 — Peter Lynch undervalued (0.80); earnings yield beats bond yields (4.54%).
  • PEG Ratio 0.80 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 4.54% — roughly competitive with bond yields (~4.3%), moderate risk-reward.

Overall SharesGrow Score: 66/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
66/100
SG Score
View full scorecard →
VALUE
88/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
55/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
41/100
→ Income
GROWTH
100/100
→ Income
INCOME
100/100
→ Income

Valuation Snapshot — XOMAO

Valuation Multiples
P/E (TTM)22.0
Forward P/E23.2
PEG Ratio0.80
Forward PEG0.80
P/B Ratio6.23
P/S Ratio8.17
EV/EBITDA33.1
Per Share Data
EPS (TTM)$1.63
Forward EPS (Est.)$1.10
Book Value / Share$5.75
Revenue / Share$2.88
FCF / Share$0.15
Yields & Fair Value
Earnings Yield4.54%
Forward Earnings Yield4.31%
Dividend Yield0.00%
Graham Number$14.50
SharesGrow IV$14.46 (-43.5%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -0.5 0.00 -0.54 4.57 -
2017 18.6 -0.17 46.88 5.15 -
2018 -7.9 0.03 5.64 19.99 -
2019 -120.7 2.70 5.44 13.02 -
2020 35.4 -0.18 5.45 16.03 -
2021 14.9 -0.94 1.66 6.17 1.49%
2022 -12.3 0.03 1.69 34.84 2.61%
2023 -5.2 -0.05 2.39 44.60 2.58%
2024 -22.2 0.38 3.75 10.79 1.78%
2025 15.1 -0.08 4.60 9.17 1.14%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-8.89 $5.56M $-53.53M -962.1%
2017 $0.73 $52.69M $14.6M 27.7%
2018 $-1.59 $5.3M $-13.34M -251.8%
2019 $-0.88 $18.37M $-7.7M -41.9%
2020 $1.16 $29.39M $13.3M 45.3%
2021 $1.30 $38.16M $15.8M 41.4%
2022 $-1.50 $6.03M $-17.1M -283.8%
2023 $-4.04 $4.76M $-40.83M -858.2%
2024 $-0.71 $28.49M $-13.82M -48.5%
2025 $1.46 $52.15M $31.71M 60.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $1.10 $0.63 – $1.86 $66.23M $51.7M – $92.04M 1
2027 $0.69 $0.39 – $1.16 $60.95M $35.78M – $99.77M 1
2028 $1.80 $1.03 – $3.04 $81.45M $54.53M – $124.76M 1
2029 $2.55 $1.45 – $4.30 $97.45M $65.24M – $149.26M 1
2030 $3.07 $1.75 – $5.18 $120.65M $80.77M – $184.8M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message